Boston Scientific Announces Acquisition of Obsidio, Inc.

Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio MARLBOROUGH, Mass., Aug. 15, 2022 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) tod... Devices, Interventional, Mergers & Acquisitions Boston Scientific, Obsidio, Gel Embolic Material, embolization
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news